The CETP I405V polymorphism is associated with an increased risk of Alzheimer’s disease
Article first published online: 29 DEC 2011
DOI: 10.1111/j.1474-9726.2011.00777.x
© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
Additional Information
How to Cite
Yu, L., Shulman, J. M., Chibnik, L., Leurgans, S., Schneider, J. A., De Jager, P. L. and Bennett, D. A. (2012), The CETP I405V polymorphism is associated with an increased risk of Alzheimer’s disease. Aging Cell, 11: 228–233. doi: 10.1111/j.1474-9726.2011.00777.x
Publication History
- Issue published online: 15 MAR 2012
- Article first published online: 29 DEC 2011
- Accepted manuscript online: 28 NOV 2011 02:07PM EST
- Accepted for publication 18 November 2011
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease, Current Genetic Medicine Reports, 2013, 1, 1, 39
- 2, , , , , , Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older, Neurobiology of Aging, 2012, 33, 8, 1851.e7

1474-9726/asset/olbannerleft.jpg?v=1&s=ca71531d833ba5d977a7ee9350874a52db28aa9c)
1474-9726/asset/olbannerright.jpg?v=1&s=5d5fea655681c8d0bf2a59a69b23ef647b137403)
